Rhodococcus equi: The many facets of a pathogenic actinomycete

Veterinary Microbiology

Volumn 167, Issue 1-2, 2013, Pages 9-33

  Vázquez Boland, José A ^a,b   Giguère, Steeve ^c   Hapeshi, Alexia ^a   MacArthur, Iain ^a   Anastasi, Elisa ^a   Valero Rello, Ana ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF LEÓN   (Spain)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

Foal rhodococcosis; Pathogenic actinomycetes; Rhodococcal pneumonia; Rhodococcus equi

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAM; CHLORAMPHENICOL; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GAMITHROMYCIN; GLYCOPEPTIDE; MACROLIDE; OXAZOLIDINONE DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLONE DERIVATIVE; RIFAMPICIN; RIFAMYCIN; SULFONAMIDE; TETRACYCLINE; TILDIPIROSIN; TILMICOSIN; TRIMETHOPRIM; TULATHROMYCIN; VIRULENCE FACTOR;

ACTINOBACTERIA; ANTIBIOTIC RESISTANCE; BACTERIAL CHROMOSOME; BACTERIAL GENOME; BACTERIAL IMMUNITY; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BREEDING; CELL SURVIVAL; DRUG BIOAVAILABILITY; DRUG POTENTIATION; ENDEMIC SPECIES; EQUINE RHODOCOCCOSIS; GENOME ANALYSIS; LUNG LESION; MACROPHAGE; MOLECULAR EPIDEMIOLOGY; MOLECULAR EVOLUTION; NONHUMAN; OPPORTUNISTIC INFECTION; PARASITE; PATHOGENESIS; PATHOGENICITY; PNEUMONIA; RECOMMENDED DRUG DOSE; RESPIRATORY TRACT DISEASE; REVIEW; RHODOCOCCUS EQUI; TROPISM;

ACTINOBACTERIA (CLASS); ANIMALIA; BACTERIA (MICROORGANISMS); BOS; EQUIDAE; RHODOCOCCUS EQUI; SUIDAE;

FOAL RHODOCOCCOSIS; PATHOGENIC ACTINOMYCETES; RHODOCOCCAL PNEUMONIA; RHODOCOCCUS EQUI;

ACTINOMYCETALES INFECTIONS; ANIMALS; HORSE DISEASES; HORSES; HOST SPECIFICITY; HUMANS; PHAGOCYTOSIS; PLASMIDS; RHODOCOCCUS EQUI;

EID: 84889090990     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2013.06.016     Document Type: Review

References (248)

1. Adkins B., Leclerc C., Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 2004, 4:553-564.
2. Al Akhrass F., Al W.I., Chaftari A.M., Reitzel R., Jiang Y., Ghannoum M., Tarrand J., Hachem R., Raad I. Rhodococcus bacteremia in cancer patients is mostly catheter related and associated with biofilm formation. PLoS ONE 2012, 7:e32945.
3. Arlotti M., Zoboli G., Moscatelli G.L., Magnani G., Maserati R., Borghi V., Andreoni M., Libanore M., Bonazzi L., Piscina A., Ciammarughi R. Rhodococcus equi infection in HIV-positive subjects: a retrospective analysis of 24 cases. Scand. J. Infect. Dis. 1996, 28:463-467.
4. Arora K., Whiteford D.C., Lau-Bonilla D., Davitt C.M., Dahl J.L. Inactivation of lsr2 results in a hypermotile phenotype in Mycobacterium smegmatis. J. Bacteriol. 2008, 190:4291-4300.
5. Arya B., Hussian S., Hariharan S. Rhodococcus equi pneumonia in a renal transplant patient: a case report and review of literature. Clin. Transplant. 2004, 18:748-752.
6. Ashour J., Hondalus M.K. Phenotypic mutants of the intracellular actinomycete Rhodococcus equi created by in vivo Himar1 transposon mutagenesis. J. Bacteriol. 2003, 185:2644-2652.
7. Asoh N., Watanabe H., Fines-Guyon M., Watanabe K., Oishi K., Kositsakulchai W., Sanchai T., Kunsuikmengrai K., Kahintapong S., Khantawa B., Tharavichitkul P., Sirisanthana T., Nagatake T. Emergence of rifampin-resistant Rhodococcus equi with several types of mutations in the rpoB gene among AIDS patients in northern Thailand. J. Clin. Microbiol. 2003, 41:2337-2340.
8. Baba H., Nada T., Ohkusu K., Ezaki T., Hasegawa Y., Paterson D.L. First case of bloodstream infection caused by Rhodococcus erythropolis. J. Clin. Microbiol. 2009, 47:2667-2669.
9. Bagdure S.R., Fisher M.A., Ryan M.E., Khasawneh F.A. Rhodococcus erythropolis encephalitis in patient receiving rituximab. Emerg. Infect. Dis. 2012, 18:1377-1379.
10. Benoit S., Benachour A., Taouji S., Auffray Y., Hartke A. H(2)O(2), which causes macrophage-related stress, triggers induction of expression of virulence-associated plasmid determinants in Rhodococcus equi. Infect. Immun. 2002, 70:3768-3776.
11. Benoit S., Benachour A., Taouji S., Auffray Y., Hartke A. Induction of vap genes encoded by the virulence plasmid of Rhodococcus equi during acid tolerance response. Res. Microbiol. 2001, 152:439-449.
12. Berghaus L.J., Giguére S., Sturgill T.L., Bade D., Malinski T.J., Huang R. Plasma pharmacokinetics, pulmonary distribution, and in vitro activity of gamithromycin in foals. J. Vet. Pharmacol. Ther. 2012, 35:59-66.
13. Boyd N.K., Cohen N.D., Lim W.S., Martens R.J., Chaffin M.K., Ball J.M. Temporal changes in cytokine expression of foals during the first month of life. Vet. Immunol. Immunopathol. 2003, 92:75-85.
14. Breathnach C.C., Sturgill-Wright T., Stiltner J.L., Adams A.A., Lunn D.P., Horohov D.W. Foals are interferon gamma-deficient at birth. Vet. Immunol. Immunopathol. 2006, 112:199-209.
15. Broker D., Arenskotter M., Legatzki A., Nies D.H., Steinbuchel A. Characterization of the 101-kilobase-pair megaplasmid pKB1, isolated from the rubber-degrading bacterium Gordonia westfalica Kb1. J. Bacteriol. 2004, 186:212-225.
16. Burton A.J., Giguère S., Sturgill T.L., Berghaus L.J., Slovis N.M., Whitman J.L., Levering C., Cohen N.D. Macrolide- and rifampin-resistant Rhodococcus equi on horse breeding farm, Kentucky, USA. Emerg. Infect. Dis. 2013, 19:282-285.
17. Byrne B.A., Prescott J.F., Palmer G.H., Takai S., Nicholson V.M., Alperin D.C., Hines S.A. Virulence plasmid of Rhodococcus equi contains inducible gene family encoding secreted proteins. Infect. Immun. 2001, 69:650-656.
18. Byrne G.A., Russell D.A., Chen X., Meijer W.G. Transcriptional regulation of the virR operon of the intracellular pathogen Rhodococcus equi. J. Bacteriol. 2007, 189:5082-5089.
19. Calhoun D.H., Bonner C.A., Gu W., Xie G., Jensen R.A. The emerging periplasm-localized subclass of AroQ chorismate mutases, exemplified by those from Salmonella typhimurium and Pseudomonas aeruginosa. Genome Biol. 2001, 2. research0030.1-0030.16.
20. Carlson K., Kuskie K., Chaffin K., Libal M., Giguère S., Lawhon S., Cohen N. Antimicrobial activity of tulathromycin and 14 other antimicrobials against virulent Rhodococcus equi in vitro. Vet. Ther. 2010, 11:E1-E9.
21. Casali N., Riley L.W. A phylogenomic analysis of the Actinomycetales mce operons. BMC Genomics 2007, 8:60.
22. Caston S.S., McClure S.R., Martens R.J., Chaffin M.K., Miles K.G., Griffith R.W., Cohen N.D. Effect of hyperimmune plasma on the severity of pneumonia caused by Rhodococcus equi in experimentally infected foals. Vet. Ther. 2006, 7:361-375.
23. Cauchard J., Sevin C., Ballet J.J., Taouji S. Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a protective VapA candidate vaccine. Vet. Microbiol. 2004, 104:73-81.
24. Cauchard S., Giguère S., Venner S., Muscatello G., Cauchard J., Cohen N.D., Haas A., Hines S.A., Hondalus M.K., Horohov D.W., Meijer W.G., Prescott J.F., Vázquez-Boland J. Rhodococcus research 2008-2012. Equine Vet. J. 2013, 45:523-526.
25. Chaffin M.K., Cohen N.D., Blodgett G.P., Syndergaard M. Evaluation of hematologic screening methods for early detection of Rhodococcus equi pneumonia in foals. J. Equine Vet. Sci. 2012, 32:S20.
26. Chaffin M.K., Cohen N.D., Blodgett G.P., Syndergaard M. Evaluation of ultrasonographic screening methods for early detection of Rhodococcus equi pneumonia in foals. J. Equine Vet. Sci. 2012, 32:S20-S21.
27. Chaffin M.K., Cohen N.D., Martens R.J. Chemoprophylactic effects of azithromycin against Rhodococcus equi-induced pneumonia among foals at equine breeding farms with endemic infections. J. Am. Vet. Med. Assoc. 2008, 232:1035-1047.
28. Chaffin M.K., Cohen N.D., Martens R.J., Edwards R.F., Nevill M. Foal-related risk factors associated with development of Rhodococcus equi pneumonia on farms with endemic infection. J. Am. Vet. Med. Assoc. 2003, 223:1791-1799.
29. Chaffin M.K., Cohen N.D., Martens R.J., O'Conor M., Bernstein L.R. Evaluation of the efficacy of gallium maltolate for chemoprophylaxis against pneumonia caused by Rhodococcus equi infection in foals. Am. J. Vet. Res. 2011, 72:945-957.
30. Chaffin M.K., Honnas C.M., Crabill M.R., Schneiter H.L., Brumbaugh G.W., Briner R.P. Cauda equina syndrome, diskospondylitis, and a paravertebral abscess caused by Rhodococcus equi in a foal. J. Am. Vet. Med. Assoc. 1995, 206:215-220.
31. Chaffin M.K., Martins R.J., Martens J.G. Therapeutic effects of immune plasma in foals with Rhodococcus equi pneumonia. Equine Vet. J. 1991, 12(Suppl.):23-29.
32. Chen J.M., German G.J., Alexander D.C., Ren H., Tan T., Liu J. Roles of Lsr2 in colony morphology and biofilm formation of Mycobacterium smegmatis. J. Bacteriol. 2006, 188:633-641.
33. Chirino-Trejo J.M., Prescott J.F., Yager J.A. Protection of foals against experimental Rhodococcus equi pneumonia by oral immunization. Can. J. Vet. Res. 1987, 51:444-447.
34. Cohen N.D., Chaffin M.K., Kuskie K.R., Syndergaard M.K., Blodgett G.P., Takai S. Association of perinatal exposure to airborne Rhodococcus equi with risk of pneumonia caused by R. equi in foals. Am. J. Vet. Res. 2013, 74:102-109.
35. Cohen N.D., Chaffin M.K., Martens R.J. Control and prevention of Rhodococcus equi pneumonia in foals. Compend. Contin. Educ. Pract. Vet. 2000, 22:1062-1070.
36. Cohen N.D., Chaffin M.K., Vandenplas M.L., Edwards R.F., Nevill M., Moore J.N., Martens R.J. Study of serum amyloid A concentrations as a means of achieving early diagnosis of Rhodococcus equi pneumonia. Equine Vet. J. 2005, 37:212-216.
37. Cohen N.D., Smith K.E., Ficht T.A., Takai S., Libal M.C., West B.R., delRosario L.S., Becu T., Leadon D.P., Buckley T., Chaffin M.K., Martens R.J. Epidemiologic study of results of pulse-field gel electrophoresis of isolates of Rhodococcus equi obtained from horses and horse farms. Am. J. Vet. Res. 2003, 64:153-161.
38. Colangeli R., Haq A., Arcus V.L., Summers E., Magliozzo R.S., McBride A., Mitra A.K., Radjainia M., Khajo A., Jacobs W.R., Salgame P., Alland D. The multifunctional histone-like protein Lsr2 protects mycobacteria against reactive oxygen intermediates. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4414-4418.
39. Collins M.D., Goodfellow M., Minnikin D.E. A survey of the structures of mycolic acids in Corynebacterium and related taxa. J. Gen. Microbiol. 1982, 128:129-149.
40. Coulson G.B., Agarwal S., Hondalus M.K. Characterization of the role of the pathogenicity island and vapG in the virulence of the intracellular actinomycete pathogen Rhodococcus equi. Infect. Immun. 2010, 78:3323-3334.
41. Darrah P.A., Hondalus M.K., Chen Q., Ischiropoulos H., Mosser D.M. Cooperation between reactive oxygen and nitrogen intermediates in killing of Rhodococcus equi by activated macrophages. Infect. Immun. 2000, 68:3587-3593.
42. Davis J.L., Gardner S.Y., Jones S.L., Schwabenton B.A., Papich M.G. Pharmacokinetics of azithromycin in foals after i.v. and oral dose and disposition into phagocytes. J. Vet. Pharmacol. Ther. 2002, 25:99-104.
43. Dawson T.R., Horohov D.W., Meijer W.G., Muscatello G. Current understanding of the equine immune response to Rhodococcus equi. An immunological review of R. equi pneumonia. Vet Immunol Immunopathol 2010, 135:1-11.
44. Dawson D.R., Nydam D.V., Price C.T., Graham J.E., Cynamon M.H., Divers T.J., Felippe M.J. Effects of opsonization of Rhodococcus equi on bacterial viability and phagocyte activation. Am. J. Vet. Res. 2011, 72:1465-1475.
45. Donisi A., Suardi M.G., Casari S., Longo M., Cadeo G.P., Carosi G. Rhodococcus equi infection in HIV-infected patients. AIDS 1996, 10:359-362.
46. Fernandez-Mora E., Polidori M., Luhrmann A., Schaible U.E., Haas A. Maturation of Rhodococcus equi-containing vacuoles is arrested after completion of the early endosome stage. Traffic 2005, 6:635-653.
47. Fernandez A.S., Prescott J.F., Nicholson V.M. Protective effect against Rhodococcus equi infection in mice of IgG purified from horses vaccinated with virulence associated protein (VapA)-enriched antigens. Vet. Microbiol. 1997, 56:187-192.
48. Fines M., Pronost S., Maillard K., Taouji S., Leclercq R. Characterization of mutations in the rpoB gene associated with rifampin resistance in Rhodococcus equi isolated from foals. J. Clin. Microbiol. 2001, 39:2784-2787.
49. Fitzgerald S.D., Yamini B. Rhodococcal abortion and pneumonia in an equine fetus. J. Vet. Diagn. Invest. 1995, 7:157-158.
50. Flaminio M.J., Nydam D.V., Marquis H., Matychak M.B., Giguère S. Foal monocyte-derived dendritic cells become activated upon Rhodococcus equi infection. Clin. Vaccine Immunol. 2009, 16:176-183.
51. Flynn O., Quigley F., Costello E., O'Grady D., Gogarty A., Mc G.J., Takai S. Virulence-associated protein characterisation of Rhodococcus equi isolated from bovine lymph nodes. Vet. Microbiol. 2001, 78:221-228.
52. Francis I., De Keyser A., De Backer P., Simon-Mateo C., Kalkus J., Pertry I., Ardiles-Diaz W., De Rycke R., Vandeputte O.M., El Jaziri M., Holsters M., Vereecke D. pFiD188, the linear virulence plasmid of Rhodococcus fascians D188. Mol. Plant Microbe Interact. 2012, 25:637-647.
53. Freestone J.F., Hietala S., Moulton J., Vivrette S. Acquired immunodeficiency in a seven-year-old horse. J. Am. Vet. Med. Assoc. 1987, 190:689-691.
54. Ganfornina M.D., Sanchez D. Generation of evolutionary novelty by functional shift. Bioessays 1999, 21:432-439.
55. Garcillan-Barcia M.P., Francia M.V., de la Cruz F. The diversity of conjugative relaxases and its application in plasmid classification. FEMS Microbiol. Rev. 2009, 33:657-687.
56. Garton N.J., Gilleron M., Brando T., Dan H.H., Giguère S., Puzo G., Prescott J.F., Sutcliffe I.C. A novel lipoarabinomannan from the equine pathogen Rhodococcus equi. Structure and effect on macrophage cytokine production. J. Biol. Chem. 2002, 277:31722-31733.
57. Gatfield J., Pieters J. Essential role for cholesterol in entry of mycobacteria into macrophages. Science 2000, 288:1647-1650.
58. Gey Van Pittius N.C., Gamieldien J., Hide W., Brown G.D., Siezen R.J., Beyers A.D. The ESAT-6 gene cluster of Mycobacterium tuberculosis and other high G+C Gram-positive bacteria. Genome Biol. 2001, 2. (RESEARCH0044).
59. Gey Van Pittius N.C., Sampson S.L., Lee H., Kim Y., van Helden P.D., Warren R.M. Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions. BMC Evol. Biol. 2006, 6:95.
60. Giguère S., Cohen N.D., Chaffin M.K., Hines S.A., Hondalus M.K., Prescott J.F., Slovis N.M. Rhodococcus equi: clinical manifestations, virulence, and immunity. J. Vet. Intern. Med. 2011, 25:1221-1230.
61. Giguère S., Cohen N.D., Chaffin M.K., Slovis N.M., Hondalus M.K., Hines S.A., Prescott J.F. Diagnosis, treatment, control, and prevention of infections caused by Rhodococcus equi in foals. J. Vet. Intern. Med. 2011, 25:1209-1220.
62. Giguère S., Hondalus M.K., Yager J.A., Darrah P., Mosser D.M., Prescott J.F. Role of the 85-kilobase plasmid and plasmid-encoded virulence-associated protein A in intracellular survival and virulence of Rhodococcus equi. Infect. Immun. 1999, 67:3548-3557.
63. Giguère S., Gaskin J.M., Miller C., Bowman J.L. Evaluation of a commercially available hyperimmune plasma product for prevention of naturally acquired pneumonia caused by Rhodococcus equi in foals. J. Am. Vet. Med. Assoc. 2002, 220:59-63.
64. Giguère S., Hernandez J., Gaskin J., Prescott J.F., Takai S., Miller C. Performance of five serological assays for diagnosis of Rhodococcus equi pneumonia in foals. Clin. Diagn. Lab. Immunol. 2003, 10:241-245.
65. Giguère S., Hernandez J., Gaskin J.M., Miller C., Bowman J.L. Evaluation of WBC concentration, plasma fibrinogen concentration, and an agar gel immunodiffusion test for early identification of foals with Rhodococcus equi pneumonia. J. Am. Vet. Med. Assoc. 2003, 222:775-781.
66. Giguère S., Jacks S., Roberts G.D., Hernandez J., Long M.T., Ellis C. Retrospective comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with Rhodococcus equi pneumonia. J. Vet. Intern. Med. 2004, 18:568-573.
67. Giguère S., Lavoie J.P. Rhodococcus equi vertebral osteomyelitis in 3 quarter horse colts (see comments). Equine Vet. J. 1994, 26:74-77.
68. Giguère S., Lee E., Williams E., Cohen N.D., Chaffin M.K., Halbert N., Martens R.J., Franklin R.P., Clark C.C., Slovis N.M. Determination of the prevalence of antimicrobial resistance to macrolide antimicrobials or rifampin in Rhodococcus equi isolates and treatment outcome in foals infected with antimicrobial-resistant isolates of R. equi. J. Am. Vet. Med. Assoc. 2010, 237:74-81.
69. Giguère S., Lee E.A., Guldbech K.M., Berghaus L.J. In vitro synergy, pharmacodynamics, and postantibiotic effect of 11 antimicrobial agents against Rhodococcus equi. Vet. Microbiol. 2012, 160:207-213.
70. Goodfellow M., Alderson G. The actinomycete-genus Rhodococcus: a home for the "rhodochrous" complex. J. Gen. Microbiol. 1977, 100:99-122.
71. Goodfellow M., Alderson G., Chun J. Rhodococcal systematics: problems and developments. Antonie Van Leeuwenhoek 1998, 74:3-20.
72. Gürtler V., Seviour R.J. Systematics of members of the genus Rhodococcus (Zopf 1891) Emend Goodfellow et al., 1998 - the past, present and future. Biology of Rhodococcus 2010, 1-28. Springer, Berlin, Heidelberg. H.M. Alvarez (Ed.).
73. Gustafsson A., Baverud V., Gunnarsson A., Rantzien M.H., Lindholm A., Franklin A. The association of erythromycin ethylsuccinate with acute colitis in horses in Sweden. Equine Vet. J. 1997, 29:314-318.
74. Haghighi H.R., Prescott J.F. Assessment in mice of vapA-DNA vaccination against Rhodococcus equi infection. Vet. Immunol. Immunopathol. 2005, 104:215-225.
75. Hang J., Clifford R.J., Yang Y., Riley M.C., Mody R.M., Kuschner R.A., Lesho E.P. Genome sequencing of pathogenic Rhodococcus spp. Emerg. Infect. Dis. 2012, 18:1915-1916.
76. Hapeshi A., Rodríguez H., Gonzalez P., Letek M., Fogarty U., Valero-Rello A., Scortti M., Meijer W.G., Vázquez-Boland J.A. Co-option of nitrogen metabolism in Rhodococcus equi virulence. Proceedings of the 5th International Havemeyer Workshop on Rhodococcus equi 2012, 58.
77. Harris S.P., Fujiwara N., Mealey R.H., Alperin D.C., Naka T., Goda R., Hines S.A. Identification of Rhodococcus equi lipids recognized by host cytotoxic T lymphocytes. Microbiology 2010, 156:1836-1847.
78. Harris S.P., Hines M.T., Mealey R.H., Alperin D.C., Hines S.A. Early development of cytotoxic T lymphocytes in neonatal foals following oral inoculation with Rhodococcus equi. Vet. Immunol. Immunopathol. 2011, 141:312-316.
79. Harvey R.L., Sunstrum J.C. Rhodococcus equi infection in patients with and without human immunodeficiency virus infection. Rev. Infect. Dis. 1991, 13:139-145.
80. Hietala S.K., Ardans A.A. Interaction of Rhodococcus equi with phagocytic cells from R. equi-exposed and non-exposed foals. Vet. Microbiol. 1987, 14:307-320.
81. Hietala S.K., Ardans A.A. Neutrophil phagocytic and serum opsonic response of the foal to Corynebacterium equi. Vet. Immunol. Immunopathol. 1987, 14:279-294.
82. Higuchi T., Arakawa T., Hashikura S., Inui T., Senba H., Takai S. Effect of prophylactic administration of hyperimmune plasma to prevent Rhodococcus equi infection on foals from endemically affected farms. Zentralbl. Veterinarmed. B 1999, 46:641-648.
83. Hillidge C.J. Use of erythromycin-rifampin combination in treatment of Rhodococcus equi pneumonia. Vet. Microbiol. 1987, 14:337-342.
84. Hines M.T., Paasch K.M., Alperin D.C., Palmer G.H., Westhoff N.C., Hines S.A. Immunity to Rhodococcus equi: antigen-specific recall responses in the lungs of adult horses. Vet. Immunol. Immunopathol. 2001, 79:101-114.
85. Hines S.A., Stone D.M., Hines M.T., Alperin D.C., Knowles D.P., Norton L.K., Hamilton M.J., Davis W.C., McGuire T.C. Clearance of virulent but not avirulent Rhodococcus equi from the lungs of adult horses is associated with intracytoplasmic gamma interferon production by CD4(+) and CD8(+) T lymphocytes. Clin. Diagn. Lab. Immunol. 2003, 10:208-215.
86. Hondalus M.K., Diamond M.S., Rosenthal L.A., Springer T.A., Mosser D.M. The intracellular bacterium Rhodococcus equi requires Mac-1 to bind to mammalian cells. Infect. Immun. 1993, 61:2919-2929.
87. Hondalus M.K., Mosser D.M. Survival and replication of Rhodococcus equi in macrophages. Infect. Immun. 1994, 62:4167-4175.
88. Hong C.B., Donahue J.M. Rhodococcus equi-associated necrotizing lymphadenitis in a llama. J. Comp. Pathol. 1995, 113:85-88.
89. Hooper-McGrevy K.E., Giguère S., Wilkie B.N., Prescott J.F. Evaluation of equine immunoglobulin specific for Rhodococcus equi virulence-associated proteins A and C for use in protecting foals against Rhodococcus equi-induced pneumonia. Am. J. Vet. Res. 2001, 62:1307-1313.
90. Hooper-McGrevy K.E., Wilkie B.N., Prescott J.F. Virulence-associated protein-specific serum immunoglobulin G-isotype expression in young foals protected against Rhodococcus equi pneumonia by oral immunization with virulent R. equi. Vaccine 2005, 23:5760-5767.
91. Horowitz M.L., Cohen N.D., Takai S., Becu T., Chaffin M.K., Chu K.K., Magdesian K.G., Martens R.J. Application of Sartwell's model (lognormal distribution of incubation periods) to age at onset and age at death of foals with Rhodococcus equi pneumonia as evidence of perinatal infection. J. Vet. Intern. Med. 2001, 15:171-175.
92. Hurley J.R., Begg A.P. Failure of hyperimmune plasma to prevent pneumonia caused by Rhodococcus equi in foals. Aust. Vet. J. 1995, 72:418-420.
93. Jacks S., Giguère S. Effects of inoculum size on cell-mediated and humoral immune responses of foals experimentally infected with Rhodococcus equi: a pilot study. Vet. Immunol. Immunopathol. 2010, 133:282-286.
94. Jacks S., Giguère S., Crawford P.C., Castleman W.L. Experimental infection of neonatal foals with Rhodococcus equi triggers adult-like gamma interferon induction. Clin. Vaccine Immunol. 2007, 14:669-677.
95. Jacks S., Giguère S., Gronwall P.R., Brown M.P., Merritt K.A. Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foals. Am. J. Vet. Res. 2001, 62:1870-1875.
96. Jacks S., Giguère S., Nguyen A. In vitro susceptibilities of Rhodococcus equi and other common equine pathogens to azithromycin, clarithromycin and 20 other antimicrobials. Antimicrob. Agents Chemother. 2003, 47:1742-1745.
97. Jain S., Bloom B.R., Hondalus M.K. Deletion of vapA encoding Virulence Associated Protein A attenuates the intracellular actinomycete Rhodococcus equi. Mol. Microbiol. 2003, 50:115-128.
98. Janicek J.C., Kramer J., Coates J.R., Lattimer J.C., Lacarrubba A.M., Messer N.T. Intracranial abscess caused by Rhodococcus equi infection in a foal. J. Am. Vet. Med. Assoc. 2006, 228:251-253.
99. Jeckel S., Holmes P., King S., Whatmore A.M., Kirkwood I. Disseminated Rhodococcus equi infection in goats in the UK. Vet. Rec. 2011, 169:56.
100. Johns I.C., Desrochers A., Wotman K.L., Sweeney R.W. Presumed immune-mediated hemolytic anemia in two foals with Rhodococcus equi infection. J. Vet. Emerg. Crit. Care (San Antonio) 2011, 21:273-278.
101. Johnson J.A., Prescott J.F., Markham R.J. The pathology of experimental Corynebacterium equi infection in foals following intrabronchial challenge. Vet. Pathol. 1983, 20:440-449.
102. Jordan M.C., Harrington J.R., Cohen N.D., Tsolis R.M., Dangott L.J., Weinberg E.D., Martens R.J. Effects of iron modulation on growth and viability of Rhodococcus equi and expression of virulence-associated protein A. Am. J. Vet. Res. 2003, 64:1337-1346.
103. Joshi S.M., Pandey A.K., Capite N., Fortune S.M., Rubin E.J., Sassetti C.M. Characterization of mycobacterial virulence genes through genetic interaction mapping. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:11760-11765.
104. + T-lymphocyte-deficient transgenic mice. Infect. Immun. 1993, 61:4929-4932.
105. Kanaly S.T., Hines S.A., Palmer G.H. Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia. Infect. Immun. 1995, 63:3037-3041.
106. Kanaly S.T., Hines S.A., Palmer G.H. Transfer of a CD4+Th1 cell line to nude mice effects clearance of Rhodococcus equi from the lung. Infect. Immun. 1996, 64:1126-1132.
107. Kasuga-Aoki H., Takai S., Sasaki Y., Tsubaki S., Madarame H., Nakane A. Tumour necrosis factor and interferon-gamma are required in host resistance against virulent Rhodococcus equi infection in mice: cytokine production depends on the virulence levels of R. equi. Immunology 1999, 96:122-127.
108. Kedlaya I., Ing M.B., Wong S.S. Rhodococcus equi infections in immunocompetent hosts: case report and review. Clin. Infect. Dis. 2001, 32:E39-E46.
109. Kenney D.G., Robbins S.C., Prescott J.F., Kaushik A., Baird J.D. Development of reactive arthritis and resistance to erythromycin and rifampin in a foal during treatment for Rhodococcus equi pneumonia. Equine Vet. J. 1994, 26:246-248.
110. Kinne J., Madarame H., Takai S., Jose S., Wernery U. Disseminated Rhodococcus equi infection in dromedary camels (Camelus dromedarius). Vet. Microbiol. 2011, 149:269-272.
111. Komijn R.E., Wisselink H.J., Rijsman V.M., Stockhofe-Zurwieden N., Bakker D., van Zijderveld F.G., Eger T., Wagenaar J.A., Putirulan F.F., Urlings B.A. Granulomatous lesions in lymph nodes of slaughter pigs bacteriologically negative for Mycobacterium avium subsp. avium and positive for Rhodococcus equi. Vet. Microbiol. 2007, 120:352-357.
112. Larkin M.J., Kulakov L.A., Allen C.C. Biodegradation and Rhodococcus-masters of catabolic versatility. Curr. Opin. Biotechnol. 2005, 16:282-290.
113. Larkin M.J., Kulakov L.A., Allen C.C.R. Genomes and plasmids in Rhodococcus. Biology of Rhodococcus 2010, 73-90. Springer, Berlin, Heidelberg. H.M. Alvarez (Ed.).
114. Letek M., Gonzalez P., Macarthur I., Rodriguez H., Freeman T.C., Valero-Rello A., Blanco M., Buckley T., Cherevach I., Fahey R., Hapeshi A., Holdstock J., Leadon D., Navas J., Ocampo A., Quail M.A., Sanders M., Scortti M.M., Prescott J.F., Fogarty U., Meijer W.G., Parkhill J., Bentley S.D., Vazquez-Boland J.A. The genome of a pathogenic Rhodococcus: cooptive virulence underpinned by key gene acquisitions. PLoS Genet. 2010, 6:e1001145.
115. Letek M., Ocampo-Sosa A.A., Sanders M., Fogarty U., Buckley T., Leadon D.P., Gonzalez P., Scortti M., Meijer W.G., Parkhill J., Bentley S., Vazquez-Boland J.A. Evolution of the Rhodococcus equi vap pathogenicity island seen through comparison of host-associated vapA and vapB virulence plasmids. J. Bacteriol. 2008, 190:5797-5805.
116. Liu M., Bordin A., Liu T., Russell K., Cohen N. Gene expression of innate Th1-, Th2-, and Th17-type cytokines during early life of neonatal foals in response to Rhodococcus equi. Cytokine 2011, 56:356-364.
117. Liu T., Nerren J., Liu M., Martens R., Cohen N. Basal and stimulus-induced cytokine expression is selectively impaired in peripheral blood mononuclear cells of newborn foals. Vaccine 2009, 27:674-683.
118. Lopez A.M., Hines M.T., Palmer G.H., Alperin D.C., Hines S.A. Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi. Clin. Diagn. Lab. Immunol. 2002, 9:1270-1276.
119. Lopez A.M., Hines M.T., Palmer G.H., Knowles D.P., Alperin D.C., Hines S.A. Analysis of anamnestic immune responses in adult horses and priming in neonates induced by a DNA vaccine expressing the vapA gene of Rhodococcus equi. Vaccine 2003, 21:3815-3825.
120. Lopez A.M., Townsend H.G., Allen A.L., Hondalus M.K. Safety and immunogenicity of a live-attenuated auxotrophic candidate vaccine against the intracellular pathogen Rhodococcus equi. Vaccine 2008, 26:998-1009.
121. Luhrmann A., Mauder N., Sydor T., Fernandez-Mora E., Schulze-Luehrmann J., Takai S., Haas A. Necrotic death of Rhodococcus equi-infected macrophages is regulated by virulence-associated plasmids. Infect. Immun. 2004, 72:853-862.
122. Lynch M., Katju V. The altered evolutionary trajectories of gene duplicates. Trends Genet. 2004, 20:544-549.
123. MacArthur I., Parreira V.R., Lepp D., Mutharia L.M., Vazquez-Boland J.A., Prescott J.F. The sensor kinase MprB is required for Rhodococcus equi virulence. Vet. Microbiol. 2011, 147:133-141.
124. Madarame H., Takai S., Matsumoto C., Minamiyama K., Sasaki Y., Tsubaki S., Hasegawa Y., Nakane A. Virulent and avirulent Rhodococcus equi infection in T-cell deficient athymic nude mice: pathologic, bacteriologic and immunologic responses. FEMS Immunol. Med. Microbiol. 1997, 17:251-262.
125. Madarame H., Yaegashi R., Fukunaga N., Matsukuma M., Mutoh K., Morisawa N., Sasaki Y., Tsubaki S., Hasegawa Y., Takai S. Pathogenicity of Rhodococcus equi strains possessing virulence-associated 15- to 17-kDa and 20-kDa antigens: experimental and natural cases in pigs. J. Comp. Pathol. 1998, 119:397-405.
126. Madigan J.E., Hietala S., Muller N. Protection against naturally acquired Rhodococcus equi pneumonia in foals by administration of hyperimmune plasma. J. Reprod. Fertil. Suppl. 1991, 44:571-578.
127. Madison J.B., Scarratt W.K. Immune-mediated polysynovitis in four foals. J. Am. Vet. Med. Assoc. 1988, 192:1581-1584.
128. Magnusson H. Spezifische infektiose Pneumoniae beim Fohlen. Ein Neuer Eiterreger beim Pferd. Arch. Wiss. Prakt. Tierheilkd. 1923, 50:22-37.
129. Makrai L., Takai S., Tamura M., Tsukamoto A., Sekimoto R., Sasaki Y., Kakuda T., Tsubaki S., Varga J., Fodor L., Solymosi N., Major A. Characterization of virulence plasmid types in Rhodococcus equi isolates from foals, pigs, humans and soil in Hungary. Vet. Microbiol. 2002, 88:377-384.
130. Makrai L., Takayama S., Denes B., Hajtos I., Sasaki Y., Kakuda T., Tsubaki S., Major A., Fodor L., Varga J., Takai S. Characterization of virulence plasmids and serotyping of Rhodococcus equi isolates from submaxillary lymph nodes of pigs in Hungary. J. Clin. Microbiol. 2005, 43:1246-1250.
131. Martens J.G., Martens R.J., Renshaw H.W. Rhodococcus (Corynebacterium) equi: bactericidal capacity of neutrophils from neonatal and adult horses. Am. J. Vet. Res. 1988, 49:295-299.
132. Martens R.J., Cohen N.D., Chaffin M.K., Takai S., Doherty C.L., Angulo A.B., Edwards R.E. Evaluation of 5 serologic assays to detect Rhodococcus equi pneumonia in foals. J. Am. Vet. Med. Assoc. 2002, 221:825-833.
133. Martens R.J., Cohen N.D., Jones S.L., Moore T.A., Edwards J.F. Protective role of neutrophils in mice experimentally infected with Rhodococcus equi. Infect. Immun. 2005, 73:7040-7042.
134. Martens R.J., Martens J.G., Fiske R.A. Rhodococcus equi foal pneumonia: pathogenesis and immunoprophylaxis. Proc. Am. Assoc. Equine Pract. 1989, 35:189-213.
135. Martens R.J., Martens J.G., Fiske R.A. Failure of passive immunisation by colostrum from immunised mares to protect foals against Rhodococcus equi pneumonia. Equine Vet. J. 1991, 12(Suppl.):19-22.
136. Martens R.J., Martens J.G., Fiske R.A., Hietala S.K. Rhodococcus equi foal pneumonia: protective effects of immune plasma in experimentally infected foals. Equine Vet. J. 1989, 21:249-255.
137. McCracken J.L., Slovis N.M. Use of thoracic ultrasound for the prevention of Rhodococcus equi pneumonia on endemic farms. Proc. Am. Assoc. Equine Pract. 2009, 55:38-44.
138. McLennan D.A. The concept of co-option: why evolution often looks miraculous. Evo Devo Outreach 2008, 1:247-258.
139. McLeod M.P., Warren R.L., Hsiao W.W., Araki N., Myhre M., Fernandes C., Miyazawa D., Wong W., Lillquist A.L., Wang D., Dosanjh M., Hara H., Petrescu A., Morin R.D., Yang G., Stott J.M., Schein J.E., Shin H., Smailus D., Siddiqui A.S., Marra M.A., Jones S.J., Holt R., Brinkman F.S., Miyauchi K., Fukuda M., Davies J.E., Mohn W.W., Eltis L.D. The complete genome of Rhodococcus sp. RHA1 provides insights into a catabolic powerhouse. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:15582-15587.
140. McMinn E.J., Alderson G., Dodson H.I., Goodfellow M., Ward A.C. Genomic and phenomic differentiation of Rhodococcus equi and related strains. Antonie Van Leeuwenhoek 2000, 78:331-340.
141. Miranda-Casoluengo R., Coulson G.B., Miranda-Casoluengo A., Vazquez-Boland J.A., Hondalus M.K., Meijer W.G. The hydroxamate siderophore rhequichelin is required for virulence of the pathogenic actinomycete Rhodococcus equi. Infect. Immun. 2012, 80:4106-4114.
142. Miranda-Casoluengo R., Miranda-Casoluengo A.A., O'Connell E.P., Fahey R.J., Boland C.A., Vazquez-Boland J.A., Meijer W.G. The vapA co-expressed virulence plasmid gene vcgB (orf10) of the intracellular actinomycete Rhodococcus equi. Microbiology 2011, 157:2357-2368.
143. Miranda-CasoLuengo R., Prescott J.F., Vazquez-Boland J.A., Meijer W.G. The intracellular pathogen Rhodococcus equi produces a catecholate siderophore required for saprophytic growth. J. Bacteriol. 2008, 190:1631-1637.
144. Mohn W.W., van der Geize R., Stewart G.R., Okamoto S., Liu J., Dijkhuizen L., Eltis L.D. The actinobacterial mce4 locus encodes a steroid transporter. J. Biol. Chem. 2008, 283:35368-35374.
145. Mongodin E.F., Shapir N., Daugherty S.C., DeBoy R.T., Emerson J.B., Shvartzbeyn A., Radune D., Vamathevan J., Riggs F., Grinberg V., Khouri H., Wackett L.P., Nelson K.E., Sadowsky M.J. Secrets of soil survival revealed by the genome sequence of Arthrobacter aurescens TC1. PLoS Genet. 2006, 2:e214.
146. Muller N.S., Madigan J.E. Methods of implementation of an immunoprophylaxis program for the prevention of Rhodococcus equi pneumonia: results of a 5-year field study. Proc. Am. Assoc. Equine Pract. 1992, 38:193-201.
147. Munoz-Elias E.J., McKinney J.D. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat. Med. 2005, 11:638-644.
148. Muntaner L., Leyes M., Payeras A., Herrera M., Gutierrez A. Radiologic features of Rhodococcus equi pneumonia in AIDS. Eur. J. Radiol. 1997, 24:66-70.
149. Muscatello G., Anderson G.A., Gilkerson J.R., Browning G.F. Associations between the ecology of virulent Rhodococcus equi and the epidemiology of R. equi pneumonia on Australian thoroughbred farms. Appl. Environ. Microbiol. 2006, 72:6152-6160.
150. Muscatello G., Leadon D.P., Klayt M., Ocampo-Sosa A., Lewis D.A., Fogarty U., Buckley T., Gilkerson J.R., Meijer W.G., Vazquez-Boland J.A. Rhodococcus equi infection in foals: the science of 'rattles'. Equine Vet. J. 2007, 39:470-478.
151. Navas J., Gonzalez-Zorn B., Ladron N., Garrido P., Vazquez-Boland J.A. Identification and mutagenesis by allelic exchange of choE, encoding a cholesterol oxidase from the intracellular pathogen Rhodococcus equi. J. Bacteriol. 2001, 183:4796-4805.
152. Nerren J.R., Martens R.J., Payne S., Murrell J., Butler J.L., Cohen N.D. Age-related changes in cytokine expression by neutrophils of foals stimulated with virulent Rhodococcus equi in vitro. Vet. Immunol. Immunopathol. 2009, 127:212-219.
153. Nordmann P., Ronco E. In-vitro antimicrobial susceptibility of Rhodococcus equi. J. Antimicrob. Chemother. 1992, 29:383-393.
154. Nordmann P., Ronco E., Nauciel C. Role of T-lymphocyte subsets in Rhodococcus equi infection. Infect. Immun. 1992, 60:2748-2752.
155. Ocampo-Sosa A.A., Lewis D.A., Navas J., Quigley F., Callejo R., Scortti M., Leadon D.P., Fogarty U., Vazquez-Boland J.A. Molecular epidemiology of Rhodococcus equi based on traA, vapA, and vapB virulence plasmid markers. J. Infect. Dis. 2007, 196:763-769.
156. Olchowy T.W. Vertebral body osteomyelitis due to Rhodococcus equi in two Arabian foals (see comments). Equine Vet. J. 1994, 26:79-82.
157. Oliveira A.F., Ruas L.P., Cardoso S.A., Soares S.G., Roque-Barreira M.C. Vaccination of mice with salmonella expressing VapA: mucosal and systemic Th1 responses provide protection against Rhodococcus equi infection. PLoS ONE 2010, 5:e8644.
158. Ouellet H., Johnston J.B., de Montellano P.R. Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosis. Trends Microbiol. 2011, 19:530-539.
159. Pandey A.K., Sassetti C.M. Mycobacterial persistence requires the utilization of host cholesterol. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:4376-4380.
160. Pargass I.S., Wills T.B., Davis W.C., Wardrop K.J., Alperin D.C., Hines S.A. The influence of age and Rhodococcus equi infection on CD1 expression by equine antigen presenting cells. Vet. Immunol. Immunopathol. 2009, 130:197-209.
161. Park H.D., Guinn K.M., Harrell M.I., Liao R., Voskuil M.I., Tompa M., Schoolnik G.K., Sherman D.R. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol. Microbiol. 2003, 48:833-843.
162. Patton K.M., McGuire T.C., Hines M.T., Mealey R.H., Hines S.A. Rhodococcus equi-specific cytotoxic T lymphocytes in immune horses and development in asymptomatic foals. Infect. Immun. 2005, 73:2083-2093.
163. Pei Y., Dupont C., Sydor T., Haas A., Prescott J.F. Cholesterol oxidase (ChoE) is not important in the virulence of Rhodococcus equi. Vet. Microbiol. 2006, 118:240-246.
164. Pei Y., Nicholson V., Woods K., Prescott J.F. Immunization by intrabronchial administration to 1-week-old foals of an unmarked double gene disruption strain of Rhodococcus equi strain 103+. Vet. Microbiol. 2007, 125:100-110.
165. Pei Y., Parreira V., Nicholson V.M., Prescott J.F. Mutation and virulence assessment of chromosomal genes of Rhodococcus equi 103. Can. J. Vet. Res. 2007, 71:1-7.
166. Perkins G.A., Yeagar A., Erb H.N., Nydam D.V., Divers T.J., Bowman J.L. Survival of foals with experimentally induced Rhodococcus equi infection given either hyperimmune plasma containing R. equi antibody or normal equine plasma. Vet. Ther. 2001, 3:334-346.
167. Peters J., Block W., Oswald S., Freyer J., Grube M., Kroemer H.K., Lammer M., Lutjohann D., Venner M., Siegmund W. Oral absorption of clarithromycin is nearly abolished by chronic comedication of rifampicin in foals. Drug Metab. Dispos. 2011, 39:1643-1649.
168. Petrovski S., Dyson Z.A., Seviour R.J., Tillett D. Small but sufficient: the Rhodococcus phage RRH1 has the smallest known Siphoviridae genome at 14.2 kilobases. J. Virol. 2012, 86:358-363.
169. Petrovski S., Seviour R.J., Tillett D. Genome sequence and characterization of a Rhodococcus equi phage REQ1. Virus Genes 2013, 46:588-590.
170. Pilares L., Aguero J., Vazquez-Boland J.A., Martinez-Martinez L., Navas J. Identification of atypical Rhodococcus-like clinical isolates as Dietzia spp. by 16S rRNA gene sequencing. J. Clin. Microbiol. 2010, 48:1904-1907.
171. Porto A.C.R.C., Oliveira A.F., Fernandes W.R., Roque-Barreira M.C., Soares S.G. Oral administration in foals of a live attenuated Salmonella vaccine strain expressing vapA antigen. Proceedings of the 5th Havemeyer Workshop on Rhodococcus equi, vol. 5 2012, 81.
172. Prescott J.F. Rhodococcus equi: an animal and human pathogen. Clin. Microbiol. Rev. 1991, 4:20-34.
173. Prescott J.F., Nicholson V.M. The effects of combinations of selected antibiotics on the growth of Corynebacterium equi. J. Vet. Pharmacol. Ther. 1984, 7:61-64.
174. Prescott J.F., Nicholson V.M., Patterson M.C., Zandona Meleiro M.C., Caterino d.A., Yager J.A., Holmes M.A. Use of Rhodococcus equi virulence-associated protein for immunization of foals against R. equi pneumonia. Am. J. Vet. Res. 1997, 58:356-359.
175. Prescott mach, Kwiecien J., Delaney K. Prevention of foal mortality due to Rhodococcus equi pneumonia on an endemically affected farm. Can. Vet. J. 1989, 30:871-875.
176. Ramos-Vivas J., Pilares-Ortega L., Remuzgo-Martinez S., Padilla D., Gutierrez-Diaz J.L., Navas-Mendez J. Rhodococcus equi human clinical isolates enter and survive within human alveolar epithelial cells. Microbes Infect. 2011, 13:438-446.
177. Ren J., Prescott J.F. Analysis of virulence plasmid gene expression of intra-macrophage and in vitro grown Rhodococcus equi ATCC 33701. Vet. Microbiol. 2003, 94:167-182.
178. Ren J., Prescott J.F. The effect of mutation on Rhodococcus equi virulence plasmid gene expression and mouse virulence. Vet. Microbiol. 2004, 103:219-230.
179. Reuss S.M., Chaffin M.K., Cohen N.D. Extrapulmonary disorders associated with Rhodococcus equi infection in foals: 150 cases (1987-2007). J. Am. Vet. Med. Assoc. 2009, 235:855-863.
180. Richards J.C. Stereochemical aspects of the antigenic determinants of bacterial polysaccharides: the Rhodococcus equi capsular polysaccharides. Carbohydr. Polym. 1994, 25:253-267.
181. + and double negative T-cells in the protection of SCID/beige mice against respiratory challenge with Rhodococcus equi. Can. J. Vet. Res. 1996, 60:186-192.
182. Russell D.A., Byrne G.A., O'Connell E.P., Boland C.A., Meijer W.G. The LysR-type transcriptional regulator VirR is required for expression of the virulence gene vapA of Rhodococcus equi ATCC 33701. J. Bacteriol. 2004, 186:5576-5584.
183. Ryan C., Giguère S. Equine neonates have attenuated humoral and cell-mediated immune responses to a killed adjuvanted vaccine compared to adult horses. Clin. Vaccine Immunol. 2010, 17:1896-1902.
184. Ryan C., Giguère S., Hagen J., Hartnett C., Kalyuzhny A.E. Effect of age and mitogen on the frequency of interleukin-4 and interferon gamma secreting cells in foals and adult horses as assessed by an equine-specific ELISPOT assay. Vet. Immunol. Immunopathol. 2010, 133:66-71.
185. Salifu S.P., Casey S.A., Foley S. Isolation and characterization of soilborne virulent bacteriophages infecting the pathogen Rhodococcus equi. J. Appl. Microbiol. 2013, 114:1625-1633.
186. Salifu S.P., Valero-Rello A., Campbell S.A., Inglis N.F., Scortti M., Foley S., Vazquez-Boland J.A. Genome and proteome analysis of phage E3 infecting the soil-borne actinomycete Rhodococcus equi. Environ. Microbiol. Rep. 2013, 5:170-178.
187. Sampson S.L. Mycobacterial PE/PPE proteins at the host-pathogen interface. Clin. Dev. Immunol. 2011, 10.1155/2011/497203.
188. Scheuch E., Spieker J., Venner M., Siegmund W. Quantitative determination of the macrolide antibiotic tulathromycin in plasma and broncho-alveolar cells of foals using tandem mass spectrometry. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2007, 850:464-470.
189. Sekine M., Tanikawa S., Omata S., Saito M., Fujisawa T., Tsukatani N., Tajima T., Sekigawa T., Kosugi H., Matsuo Y., Nishiko R., Imamura K., Ito M., Narita H., Tago S., Fujita N., Harayama S. Sequence analysis of three plasmids harboured in Rhodococcus erythropolis strain PR4. Environ. Microbiol. 2006, 8:334-346.
190. Slovis N.M., McCracken J.L., Mundy G. How to use thoracic ultrasound to screen foals for Rhodococcus equi at affected farms. Proc. Am. Assoc. Equine Pract. 2005, 51:274-278.
191. Stiles B.M., Isaacs R.B., Daniel T.M., Jones D.R. Role of surgery in Rhodococcus equi pulmonary infections. J. Infect. 2002, 45:59-61.
192. Stratton-Phelps M., Wilson W.D., Gardner I.A. Risk of adverse effects in pneumonic foals treated with erythromycin versus other antibiotics: 143 cases (1986-1996). J. Am. Vet. Med. Assoc. 2000, 217:68-73.
193. Summer E.J., Liu M., Gill J.J., Grant M., Chan-Cortes T.N., Ferguson L., Janes C., Lange K., Bertoli M., Moore C., Orchard R.C., Cohen N.D., Young R. Genomic and functional analyses of Rhodococcus equi phages ReqiPepy6, ReqiPoco6, ReqiPine5, and ReqiDocB7. Appl. Environ. Microbiol. 2011, 77:669-683.
194. Sutcliffe I.C., Brown A.K., Dover L.G. The rhodococcal cell envelope: composition, organisation and biosynthesis. Biology of Rhodococcus 2010, 29-71. Springer, Berlin, Heidelberg. H.M. Alvarez (Ed.).
195. Sweeney C.R., Sweeney R.W., Divers T.J. Rhodococcus equi pneumonia in 48 foals: response to antimicrobial therapy. Vet. Microbiol. 1987, 14:329-336.
196. Sydor T., von Bargen K., Becken U., Spuerck S., Nicholson V.M., Prescott J.F., Haas A. A mycolyl transferase mutant of Rhodococcus equi lacking capsule integrity is fully virulent. Vet. Microbiol. 2008, 128:327-341.
197. Sydor T., von Bargen K., Hsu F.F., Huth G., Holst O., Wohlmann J., Becken U., Dykstra T., Sohl K., Lindner B., Prescott J.F., Schaible U.E., Utermohlen O., Haas A. Diversion of phagosome trafficking by pathogenic Rhodococcus equi depends on mycolic acid chain length. Cell. Microbiol. 2013, 15:458-473.
198. Szeredi L., Molnar T., Glavits R., Takai S., Makrai L., Denes B., Del Piero F. Two cases of equine abortion caused by Rhodococcus equi. Vet. Pathol. 2006, 43:208-211.
199. Takai S. Epidemiology of Rhodococcus equi infections: a review. Vet. Microbiol. 1997, 56:167-176.
200. Takai S., Fukunaga N., Ochiai S., Imai Y., Sasaki Y., Tsubaki S., Sekizaki T. Identification of intermediately virulent Rhodococcus equi isolates from pigs. J. Clin. Microbiol. 1996, 34:1034-1037.
201. Takai S., Fukunaga N., Ochiai S., Sakai T., Sasaki Y., Tsubaki S. Isolation of virulent and intermediately virulent Rhodococcus equi from soil and sand on parks and yards in Japan. J. Vet. Med. Sci. 1996, 58:669-672.
202. Takai S., Hidaka D., Fujii M., Shindoh Y., Murata T., Nakanishi S., Sasaki Y., Tsubaki S., Kamada M. Serum antibody responses of foals to virulence-associated 15- to 17-kilodalton antigens of Rhodococcus equi. Vet. Microbiol. 1996, 52:63-71.
203. Takai S., Hines S.A., Sekizaki T., Nicholson V.M., Alperin D.A., Osaki M., Takamatsu D., Nakamura M., Suzuki K., Ogino N., Kakuda T., Dan H., Prescott J.F. DNA sequence and comparison of virulence plasmids from Rhodococcus equi ATCC 33701 and 103. Infect. Immun. 2000, 68:6840-6847.
204. Takai S., Iie M., Watanabe Y., Tsubaki S., Sekizaki T. Virulence-associated 15- to 17-kilodalton antigens in Rhodococcus equi: temperature-dependent expression and location of the antigens. Infect. Immun. 1992, 60:2995-2997.
205. Takai S., Imai Y., Fukunaga N., Uchida Y., Kamisawa K., Sasaki Y., Tsubaki S., Sekizaki T. Identification of virulence-associated antigens and plasmids in Rhodococcus equi from patients with AIDS. J. Infect. Dis. 1995, 172:1306-1311.
206. Takai S., Martens R.J., Julian A., Garcia R.M., Rodrigues d.F., Sasaki Y., Inuzuka K., Kakuda T., Tsubaki S., Prescott J.F. Virulence of Rhodococcus equi isolated from cats and dogs. J. Clin. Microbiol. 2003, 41:4468-4470.
207. Takai S., Morozumi Y., Higashiyama S., Tsubaki S. Nitroblue tetrazolium reduction by neutrophils of newborn foals, adult horses, and a foal infected with Rhodococcus (Corynebacterium) equi. Jpn. J. Vet. Sci. 1986, 48:405-408.
208. Takai S., Nakata I., Fukii N., Kimura Y., Sasaki Y., Kakuda T., Tsubaki S., Kondo T., Sugiura T. Isotype-specific antibody responses to Rhodococcus equi in foals on a horse-breeding farm with a persistent incidence of R. equi infection. J. Equine Sci. 2002, 13:63-70.
209. Takai S., Sekizaki T., Ozawa T., Sugawara T., Watanabe Y., Tsubaki S. Association between a large plasmid and 15- to 17-kilodalton antigens in virulent Rhodococcus equi. Infect. Immun. 1991, 9:4056-4060.
210. Takai S., Sugawara T., Watanabe Y., Sasaki Y., Tsubaki S., Sekizaki T. Effect of growth temperature on maintenance of virulent Rhodococcus equi. Vet. Microbiol. 1994, 39:187-192.
211. Takai S., Takeda K., Nakano Y., Karasawa T., Furugoori J., Sasaki Y., Tsubaki S., Higuchi T., Anzai T., Wada R., Kamada M. Emergence of rifampin-resistant Rhodococcus equi in an infected foal. J. Clin. Microbiol. 1997, 35:1904-1908.
212. Takai S., Tharavichitkul P., Takarn P., Khantawa B., Tamura M., Tsukamoto A., Takayama S., Yamatoda N., Kimura A., Sasaki Y., Kakuda T., Tsubaki S., Maneekarn N., Sirisanthana T., Kirikae T. Molecular epidemiology of Rhodococcus equi of intermediate virulence isolated from patients with and without acquired immune deficiency syndrome in Chiang Mai, Thailand. J. Infect. Dis. 2003, 188:1717-1723.
213. Tapprest J., Bouyer B., Pannequin M., Collet L., Sevin C., Le Net J.L., Cauchard J., Duquesne F., Petry S., Hans A., Laugier C., Moutou F. Atypical outbreak of rhodococcosis in adult equidae. Proceedings of the 5th International Havemeyer Workshop on Rhodococcus equi 2012, 46.
214. Tkachuk-Saad O., Lusis P., Welsh R.D., Prescott J.F. Rhodococcus equi infections in goats. Vet. Rec. 1998, 143:311-312.
215. Torres-Tortosa M., Arrizabalaga J., Villanueva J.L., Galvez J., Leyes M., Valencia M.E., Flores J., Pena J.M., Perez-Cecilia E., Quereda C. Prognosis and clinical evaluation of infection caused by Rhodococcus equi in HIV-infected patients: a multicenter study of 67 cases. Chest 2003, 123:1970-1976.
216. Toyooka K., Takai S., Kirikae T. Rhodococcus equi can survive a phagolysosomal environment in macrophages by suppressing acidification of the phagolysosome. J. Med. Microbiol. 2005, 54:1007-1015.
217. Tripathi V.N., Harding W.C., Willingham-Lane J.M., Hondalus M.K. Conjugal transfer of a virulence plasmid in the opportunistic intracellular actinomycete Rhodococcus equi. J. Bacteriol. 2012, 194:6790-6801.
218. True J.R., Carroll S.B. Gene co-option in physiological and morphological evolution. Annu. Rev. Cell Dev. Biol. 2002, 18:53-80.
219. Valero-Rello A., Hapeshi A., Gonzalez P., Rodríguez H., Langthorne M., Yoo C., Buckley T., Fogarty U., Vazquez-Boland J.A. The determinants of Rhodococcus equi host tropism: sequencing of the bovine type plasmid pVAPN and comparative roles of vapA, vapB and vapN in virulence. Proceedings of the 5th International Havemeyer Workshop on Rhodococcus equi 2012, 67.
220. van der Geize R., de Jong W., Hessels G.I., Grommen A.W., Jacobs A.A., Dijkhuizen L. A novel method to generate unmarked gene deletions in the intracellular pathogen Rhodococcus equi using 5-fluorocytosine conditional lethality. Nucleic Acids Res. 2008, 36:e151.
221. van der Geize R., Dijkhuizen L. Harnessing the catabolic diversity of rhodococci for environmental and biotechnological applications. Curr. Opin. Microbiol. 2004, 7:255-261.
222. van der Geize R., Grommen A.W., Hessels G.I., Jacobs A.A., Dijkhuizen L. The steroid catabolic pathway of the intracellular pathogen Rhodococcus equi is important for pathogenesis and a target for vaccine development. PLoS Pathog. 2011, 7:e1002181.
223. Van der Geize R., Yam K., Heuser T., Wilbrink M.H., Hara H., Anderton M.C., Sim E., Dijkhuizen L., Davies J.E., Mohn W.W., Eltis L.D. A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:1947-1952.
224. Vazquez-Boland J.A. Rhodococcus equi virulence and vaccine development, a question of attachment. Proceedings of the 5th International Havemeyer Workshop on Rhodococcus equi 2012, 21.
225. Vazquez-Boland J.A., Letek M., Valero A., Gonzalez P., Scortti M., Fogarty U. Rhodococcus equi and its pathogenic mechanisms. Biology of Rhodococcus 2010, 331-359. Springer, Berlin, Heidelberg. H.M. Alvarez (Ed.).
226. Vazquez-Boland J.A., Prescott J.F., Meijer W.G., Leadon D.P., Hines S.A. Rhodococcus equi comes of age. Equine Vet. J. 2009, 41:93-95.
227. Venner M., Astheimer K., Lammer M., Giguère S. Efficacy of mass antimicrobial treatment of foals with subclinical pulmonary abscesses associated with Rhodococcus equi. J. Vet. Intern. Med. 2012, 27:171-176.
228. Venner M., Kerth R., Klug E. Evaluation of tulathromycin in the treatment of pulmonary abscesses in foals. Vet. J. 2007, 174:418-421.
229. Venner M., Peters J., Hohensteiger N., Schock B., Bornhorst A., Grube M., Adam U., Scheuch E., Weitschies W., Rosskopf D., Kroemer H.K., Siegmund W. Concentration of the macrolide antibiotic tulathromycin in broncho-alveolar cells is influenced by comedication of rifampicin in foals. Naunyn-Schmiedeberg's Arch. Pharmacol. 2010, 381:161-169.
230. Venner M., Reinhold B., Beyerbach M., Feige K. Efficacy of azithromycin in preventing pulmonary abscesses in foals. Vet. J. 2009, 179:301-303.
231. Venner M., Rodiger A., Laemmer M., Giguère S. Failure of antimicrobial therapy to accelerate spontaneous healing of subclinical pulmonary abscesses on a farm with endemic infections caused by Rhodococcus equi. Vet. J. 2012, 192:293-298.
232. von Bargen K., Haas A. Molecular and infection biology of the horse pathogen Rhodococcus equi. FEMS Microbiol. Rev. 2009, 33:870-891.
233. von Bargen K., Polidori M., Becken U., Huth G., Prescott J.F., Haas A. Rhodococcus equi virulence-associated protein A is required for diversion of phagosome biogenesis but not for cytotoxicity. Infect. Immun. 2009, 77:5676-5681.
234. von Bargen K., Wohlmann J., Taylor G.A., Utermohlen O., Haas A. Nitric oxide-mediated intracellular growth restriction of pathogenic Rhodococcus equi can be prevented by iron. Infect. Immun. 2011, 79:2098-2111.
235. Voskuil M.I., Schnappinger D., Visconti K.C., Harrell M.I., Dolganov G.M., Sherman D.R., Schoolnik G.K. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J. Exp. Med. 2003, 198:705-713.
236. Wagner B., Burton A., Ainsworth D. Interferon-gamma, interleukin-4 and interleukin-10 production by T helper cells reveals intact Th1 and regulatory T(R)1 cell activation and a delay of the Th2 cell response in equine neonates and foals. Vet. Res. 2010, 41:47.
237. Wall D.M., Duffy P.S., Dupont C., Prescott J.F., Meijer W.G. Isocitrate lyase activity is required for virulence of the intracellular pathogen Rhodococcus equi. Infect. Immun. 2005, 73:6736-6741.
238. Wassenaar T.M., Gaastra W. Bacterial virulence: can we draw the line?. FEMS Microbiol. Lett. 2001, 201:1-7.
239. Weinstock D.M., Brown A.E. Rhodococcus equi: an emerging pathogen. Clin. Infect. Dis. 2002, 34:1379-1385.
240. Womble A., Giguère S., Lee E.A. Pharmacokinetics of oral doxycycline and concentrations in body fluids and bronchoalveolar cells of foals. J. Vet. Pharmacol. Ther. 2007, 30:187-193.
241. Womble A., Giguère S., Murthy Y.V., Cox C., Obare E. Pulmonary disposition of tilmicosin in foals and in vitro activity against Rhodococcus equi and other common equine bacterial pathogens. J. Vet. Pharmacol. Ther. 2006, 29:561-568.
242. Yager J.A., Duder C.K., Prescott J.F., Zink M.C. The interaction of Rhodococcus equi and foal neutrophils in vitro. Vet. Microbiol. 1987, 14:287-294.
243. Yager J.A., Foster S.F., Zink M.C., Prescott J.F., Lumsden J.H. In vitro bactericidal efficacy of equine polymorphonuclear leukocytes against Corynebacterium equi. Am. J. Vet. Res. 1986, 47:438-440.
244. Yager J.A., Prescott C.A., Kramar D.P., Hannah H., Balson G.A., Croy B.A. The effect of experimental infection with Rhodococcus equi on immunodeficient mice. Vet. Microbiol. 1991, 28:363-376.
245. Yamazaki T., Kajiwara M., Itahashi K., Fujimura M. Low-dose doxapram therapy for idiopathic apnea of prematurity. Pediatr. Int. 2001, 43:124-127.
246. Yamshchikov A.V., Schuetz A., Lyon G.M. Rhodococcus equi infection. Lancet Infect. Dis. 2010, 10:350-359.
247. Zink M.C., Yager J.A., Prescott J.F., Fernando M.A. Electron microscopic investigation of intracellular events after ingestion of Rhodococcus equi by foal alveolar macrophages. Vet. Microbiol. 1987, 14:295-305.
248. Zink M.C., Yager J.A., Smart N.L. Corynebacterium equi infections in horses, 1958-1984: a review of 131 cases. Can. J. Vet. Res. 1986, 27:213-217.